Szyman Catherine M. 4
4 · Edwards Lifesciences Corp · Filed Sep 3, 2024
Insider Transaction Report
Form 4
Szyman Catherine M.
CVP, Critical Care & Vascular
Transactions
- Tax Payment
Common Stock
2024-09-03$69.96/sh−5,530$386,879→ 81,287.437 total - Award
Common Stock
2024-09-03+10,910→ 86,817.437 total
Footnotes (1)
- [F1]These restricted stock units were granted on September 3, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are 100% vested and exercisable on the grant date.